viewpoint: china has the upper hand in cancer cell therapy
.
.
| featured:
.
.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
.
.
.
.
.
the patient was treated at the royal devon & exeter nhs foundation trust.
.
.
.
.